Toggle navigation
Home
Search
Services
Blog
Contact
About
Technetium Labeled Antibodies for Diagnosis
Reno, John M.
Neorx Corporation, Seattle, WA, United States
Search 3 grants from John Reno
Search grants from Neorx Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Joint SNP and CNV calling in 1000 Genomes sequence data
Signal Transduction Components in the Vomeronasal Organ
Modeling the Chemistry of Isopenicillin N Synthase
128-Channel Automated Eeg Recording System
H202 and Oxy-Radical Stress in Catecholamine Neurons
Recently added grants:
Probing the Relationship Between Protein Kinase C and mTOR in Mitochondrial Function
Bystander gene deletions in cancer: mechanisms of therapeutic opportunities and challenges
Mechanistic clinical trial of individualized tDCS for hallucinations in schizophrenia
Multi-modal imaging of the mechanisms underlying impaired executive attention after traumatic brain injury
Molecular imaging of brain injury and repair in NFL players
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067940-001
Application #
3614580
Study Section
Project Start
1986-09-24
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Neorx Corporation
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98119
Related projects
NIH 1987
N43 CM
Technetium Labeled Antibodies for Diagnosis
Reno, John M. / Neorx Corporation
NIH 1986
N43 CM
Technetium Labeled Antibodies for Diagnosis
Reno, John M. / Neorx Corporation
Comments
Be the first to comment on this grant